BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:260cdaba2ebcac51f01dc00179f50fd255 CATEGORIES:IEC Events (for everyone) SUMMARY:IEC at SID 2022 - Portland, OR, USA DESCRIPTION:
At SID 2022 | May 18, 2022, 10:00 - 1:15 pm P DT
Oregon Convention Center | B117-B119 | Portland, OR, USA
Learn about microbiome and atopic dermatitis durin g a complimentary educational symposium during the Society for Investigativ e Dermatology (SID) 2022 annual meeting in Portland, OR. Learn more about the SID 2022 annual meeting .
Tiffany C. Scharschmidt, MD
Associate Professor |
UCSF Department of Dermatology
Heidi H. Kong, MD, MHSc <
br />Senior Investigator, Dermatology Branch/NIAMS
Adjunct Investigato
r, Laboratory of Integrative Cancer Immunology/CCR/NCI
< p>PROGRAM GOALS
10:00 – 10:10 am
10:10 – 10:40 am Skin Microbiome Signatures in Atopic Derm atitis| John Common, PhD | A*STAR
Investigating microbial communities present on the skin of atopic dermatitis (AD) patients has led to a deeper underst anding of the shifts in community diversity and functional gene pathways. T hese dynamic shifts across the flare cycle and according to the underlying endotypes of AD provide potential intervention points for topical therapies to reduce infections. We have also recently identified the shared microbio me signatures that exist between children with AD and their caregivers. Thi s supports the inclusion of family members in microbial-based strategies fo r treating recurrent paediatric AD.
10:40 – 11:10 am On -Person Adaptive Evolution of Staphylococcus aureus During Treatme nt for Atopic Dermatitis | Tami Lieberman, P hD | MIT
< span style="font-size: 15px;">Genetic variation among S. aureus strains is thought to contribute to heterogeneity in the severity of atopic dermatitis , but the degree of variation created by de novo mutation during colonizati on is not well understood. Here, I will present our results from longitudin al tracking S. aureus on-person evolution on 25 children treated for AD ove r 9 months.
11:10 – 11:25 am Heterogeneity in Cut aneous Infection Prevalence and Frequency by Timing of Atopic Dermatitis On set | Saloni Shah, BA | Thomas Jefferson U niversity
11:25 – 11:40 am Staphylococcus aureus Pr oteases Trigger Skin Inflammation via Eosinophil-Derived IL-17 Responses | Sabrina J. Nolan, PhD | Johns Hopk ins University School of Medicinie
11:40 – 11:55 am Br eak
11:55 – 12:25 pm Infant
ile Eczema and Staphylococcus aureus Agr Mutations |
Agr quorum-sensing associated toxin productions from Staphylococcus aureus play some important roles in atopic dermatitis. We analyzed longitudinal changes of infant ski n microbiome and S. aureus skin colonization in a skin care intervention st udy. Compared to previous Japanese infant cohort studies, the skin care int ervention reduced the risk of infantile eczema/atopic dermatitis and increa sed the agr-mutation rate in skin-colonized S. aureus while this interventi on did not reduce the risk of food-allergen sensitization. Food-allergen se nsitized infants at one year-old have less microbiome diversity of their sk in at one month of age independent of infantile eczema.
12:25 – 12:55 pm Host-Microbiome Metabolic Interactions in Atopic Dermati tis | Helen Alexander, MD | King ’s College London
This talk w ill focus on host-microbiome interactions in AD, to include microbial metab olites as potential mediators of host-microbiome interactions. The AD gut m icrobiome and potential metabolic cross-talk between gut and skin will also be discussed.
12:55 – 1:10 pm Botanical inhibitors of Staphylococcal Virulence: A New Path Toward Mitigating Atopic Dermatitis S everity? | Cassandra Quave, PhD | Emory University School of Medicine
1:10 – 1:15 pm Closing Comments & Adjournment | Co-Chairs, Tiffany Scharschmi dt, MD and Heidi Kong, MD, MHSc
This educational symposium presented by the IEC is offe red at no cost to attendees.
HEALTH AND SAFETY TRAVEL RESOURCES
IEC and SID will comply with state and local mandates at the ti me of the in-person meeting. Learn more here a>.
COVID-19 VACCINATION STATUS
The SID is requiring proof o
f full COVID-19 vaccination (plus booster) for admittance to ALL SID in-per
son meetings and events.
For those traveling international ly, there may be additional requirements in place. Please check with your airline and current U.S. entry guidelines .
DTSTAMP:20240329T112827 DTSTART;TZID=America/Los_Angeles:20220518T100000 DTEND;TZID=America/Los_Angeles:20220518T131500 SEQUENCE:0 TRANSP:OPAQUE END:VEVENT END:VCALENDAR